Business Description
Moderna Inc
NAICS : 325412
SIC : 2836
ISIN : US60770K1079
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.89 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.3 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 9.61 | |||||
Beneish M-Score | -3.78 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 190.8 | |||||
3-Year EBITDA Growth Rate | -64.8 | |||||
3-Year EPS without NRI Growth Rate | -83.9 | |||||
3-Year Book Growth Rate | 78.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | -51.34 | |||||
Future 3-5Y Total Revenue Growth Rate | 2 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.63 | |||||
9-Day RSI | 57.19 | |||||
14-Day RSI | 60.13 | |||||
6-1 Month Momentum % | 58.22 | |||||
12-1 Month Momentum % | -4.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.03 | |||||
Quick Ratio | 3.91 | |||||
Cash Ratio | 3.58 | |||||
Days Inventory | 44.4 | |||||
Days Sales Outstanding | 60.89 | |||||
Days Payable | 34.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.4 | |||||
Shareholder Yield % | 0.82 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.37 | |||||
Operating Margin % | -101.1 | |||||
Net Margin % | -117.41 | |||||
FCF Margin % | -72.62 | |||||
ROE % | -39.3 | |||||
ROA % | -29.66 | |||||
ROIC % | -58.09 | |||||
ROC (Joel Greenblatt) % | -187.97 | |||||
ROCE % | -28.3 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 11.1 | |||||
PB Ratio | 4.42 | |||||
Price-to-Tangible-Book | 4.55 | |||||
EV-to-EBIT | -10.11 | |||||
EV-to-Forward-EBIT | -15.6 | |||||
EV-to-EBITDA | -11.51 | |||||
EV-to-Forward-EBITDA | -17.09 | |||||
EV-to-Revenue | 9.48 | |||||
EV-to-Forward-Revenue | 11.62 | |||||
EV-to-FCF | -13.44 | |||||
Price-to-Projected-FCF | 1.33 | |||||
Price-to-Net-Current-Asset-Value | 10.18 | |||||
Price-to-Net-Cash | 12.55 | |||||
Earnings Yield (Greenblatt) % | -9.89 | |||||
FCF Yield % | -6.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Moderna Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 4,699.248 | ||
EPS (TTM) (€) | -14.591 | ||
Beta | 1.67 | ||
Volatility % | 51.39 | ||
14-Day RSI | 60.13 | ||
14-Day ATR (€) | 5.143425 | ||
20-Day SMA (€) | 128.637 | ||
12-1 Month Momentum % | -4.28 | ||
52-Week Range (€) | 65.07 - 154.22 | ||
Shares Outstanding (Mil) | 383.24 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Moderna Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Moderna Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Moderna Inc Frequently Asked Questions
What is Moderna Inc(HAM:0QF)'s stock price today?
When is next earnings date of Moderna Inc(HAM:0QF)?
Does Moderna Inc(HAM:0QF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |